Central nervous system medication use in older adults with intellectual disability: results from the successful ageing in intellectual disability study

Kate M Chitty, Elizabeth Evans, Jennifer J Torr, Teresa Iacono, Henry Brodaty, Perminder Sachdev, Julian N Trollor

    Research output: Contribution to journalArticleResearchpeer-review


    Information on the rates and predictors of polypharmacy of central nervous system medication in older people with intellectual disability is limited, despite the increased life expectancy of this group. This study examined central nervous system medication use in an older sample of people with intellectual disability.
    Original languageEnglish
    Pages (from-to)352-362
    Number of pages11
    JournalAustralian & New Zealand Journal of Psychiatry
    Issue number4
    Publication statusPublished - 2016


    • intellectual disability
    • challenging behaviour
    • central nervous system medication
    • polypharmacy

    Cite this